Cue Biopharma, Inc. Basic Shares Outstanding (Weighted Average)
Cue Biopharma, Inc. (CUE) reported Basic Shares Outstanding (Weighted Average) of 6.34 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- Cue Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 6.34M shares, a 99.27% increase year-over-year.
- Cue Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 4.81M shares, a 94.23% increase year-over-year.
- Cue Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 108.11M shares, a 45.25% increase year-over-year.
- Cue Biopharma, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 100.87M shares, a 96.90% increase year-over-year.
- Cue Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 94.73M shares, a 68.18% increase from fiscal 2024.
- Cue Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 56.33M shares, a 23.11% increase from fiscal 2023.
- Cue Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 45.75M shares, a 28.35% increase from fiscal 2022.
- Cue Biopharma, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 35.65M shares, a 13.95% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 6.34M shares 10-Q · filed 2026-08-14 | 5.57M shares 10-Q · filed 2026-08-14 | 39.75M shares derived: average of 3 quarters · filed 2026-08-14 | 55.03M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | 4.81M shares 10-Q · filed 2026-05-14 | 56.46M shares derived: average of 2 quarters · filed 2026-05-14 | 71.26M shares derived: average of 3 quarters · filed 2026-05-14 | 54.24M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | 108.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 104.49M shares derived: average of 2 quarters · filed 2026-03-16 | 70.72M shares derived: average of 3 quarters · filed 2026-08-14 | 94.73M shares 10-K · filed 2026-03-16 | ||
| 2025-09-30 | 100.87M shares 10-Q · filed 2025-11-12 | 52.03M shares derived: average of 2 quarters · filed 2026-08-14 | 90.27M shares 10-Q · filed 2025-11-12 | 45.24M shares derived: average of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | 3.18M shares 10-Q · filed 2026-08-14 | 95.46M shares 10-Q · filed 2025-08-12 | 2.83M shares 10-Q · filed 2026-08-14 | 84.86M shares 10-Q · filed 2025-08-12 | 26.70M shares derived: average of 3 quarters · filed 2026-08-14 | 32.83M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 2.48M shares 10-Q · filed 2026-05-14 | 74.25M shares 10-Q · filed 2025-05-12 | 38.45M shares derived: average of 2 quarters · filed 2026-05-14 | 42.71M shares derived: average of 3 quarters · filed 2026-05-14 | 44.58M shares derived: average of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | 74.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 62.83M shares derived: average of 2 quarters · filed 2026-03-16 | 58.61M shares derived: average of 3 quarters · filed 2026-03-16 | 56.33M shares 10-K · filed 2026-03-16 | ||
| 2024-09-30 | 51.23M shares 10-Q · filed 2025-11-12 | 50.70M shares derived: average of 2 quarters · filed 2025-11-12 | 50.29M shares 10-Q · filed 2025-11-12 | 49.52M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 50.17M shares 10-Q · filed 2025-08-12 | 49.82M shares 10-Q · filed 2025-08-12 | 48.95M shares derived: average of 3 quarters · filed 2025-08-12 | 48.30M shares derived: average of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | 49.47M shares 10-Q · filed 2025-05-12 | 48.33M shares derived: average of 2 quarters · filed 2025-05-12 | 47.67M shares derived: average of 3 quarters · filed 2025-05-12 | 46.96M shares derived: average of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | 47.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 46.78M shares derived: average of 2 quarters · filed 2025-03-31 | 46.12M shares derived: average of 3 quarters · filed 2025-03-31 | 45.75M shares 10-K · filed 2025-03-31 | ||
| 2023-09-30 | 46.36M shares 10-Q · filed 2024-11-14 | 45.58M shares derived: average of 2 quarters · filed 2024-11-14 | 45.27M shares 10-Q · filed 2024-11-14 | 43.75M shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 44.80M shares 10-Q · filed 2024-08-14 | 44.73M shares 10-Q · filed 2024-08-14 | 42.88M shares derived: average of 3 quarters · filed 2024-08-14 | 41.00M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 44.65M shares 10-Q · filed 2024-05-09 | 41.92M shares derived: average of 2 quarters · filed 2024-05-09 | 39.74M shares derived: average of 3 quarters · filed 2024-05-09 | 38.64M shares derived: average of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | 39.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 37.28M shares derived: average of 2 quarters · filed 2024-03-28 | 36.64M shares derived: average of 3 quarters · filed 2024-03-28 | 35.65M shares 10-K · filed 2024-03-28 | ||
| 2022-09-30 | 35.38M shares 10-Q · filed 2023-11-03 | 35.37M shares derived: average of 2 quarters · filed 2023-11-03 | 34.47M shares 10-Q · filed 2023-11-03 | 33.83M shares derived: average of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | 35.36M shares 10-Q · filed 2023-08-08 | 34.01M shares 10-Q · filed 2023-08-08 | 33.31M shares derived: average of 3 quarters · filed 2023-08-08 | 32.81M shares derived: average of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | 32.64M shares 10-Q · filed 2023-05-09 | 32.29M shares derived: average of 2 quarters · filed 2023-05-09 | 31.97M shares derived: average of 3 quarters · filed 2023-05-09 | |||
| 2021-12-31 | 31.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-21 | 31.63M shares derived: average of 2 quarters · filed 2023-03-21 | 31.29M shares 10-K · filed 2023-03-21 | |||
| 2021-09-30 | 31.32M shares 10-Q · filed 2022-11-14 | 31.06M shares 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |